ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings
May 27, 2021Esco Lifesciences announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation ... -
Esco, Max Planck cooperate on research of flavivirus vaccines
April 03, 2018The purpose of the project is to culture Vero cells, using a packed bed bioreactor to a high cell density, and produce live attenuated yellow fever virus (YFV).
Pharma Sources Insight January 2025
